Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to set up a longitudinal data collection study to perform a long-term follow-up of SMA patients in a real-world setting, and to standardise and homogenize the data collection process for SMA patient's data.
Treated and untreated patients will be followed based on the routine clinical practice schedule.
This is a retrospective, prospective, multicentre, non-randomized data collection study in Spain. The dataset collected is based on the TREAT-NMD SMA Core Dataset and the CuidAME steering committee consensus. The study collects pseudo-anonymized data, including data on genetic test results, clinical diagnoses, treatment, and outcome measures.
Patients will be followed based on the routine clinical practice schedule. Motor outcomes will be captured regularly, following the SMA standards of for care, for patients with a DMT every 6 months or at least once per year in patients without DMTs, for at least a 5-year follow-up period initially, which could be extended under agreement with funders of the study.
Participation in this study does not modify or influence any clinical decisions regarding the treatment the patient may receive, clinical assessments performed or frequency of visits.
The study will not collect data from patients participating in a clinical trial from the time they are enrolled. Data collected before the enrolment may be used, and data collection may continue after the end of the clinical trial. Data generated during a clinical trial could be used if written permission from the clinical trial sponsor is obtained.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects with Spinal Muscular Atrophy 5q | Subjects with Spinal Muscular Atrophy 5q |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Motor and functional status (WHO) | Motor status will be captured (all patients): WHO motor milestones: checklist that assesses whether a child can sit independently, crawl, stand with/without support, and walk with/without support. Changes in this score (loss or gain in function) and maintenance of score throughout study duration is assessed. | Yearly through study completion, an average of 5 years |
| Motor and functional status (CHOP INTEND) | Motor status will be captured (patients below two years of age): Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): maximum score of 64. | Yearly through study completion, an average of 5 years |
| Motor and functional status (HFMSE) | Motor status will be captured (patients over 36 months of age): Hammersmith Functional Motor Scale Expanded (HFMSE): maximum score of 66. | Yearly through study completion, an average of 5 years |
| Motor and functional status (RULM) | Motor status will be captured (patients obver 36 months of age): Revised Upper Limb Module (RULM): maximum score of 37. | Yearly through study completion, an average of 5 years |
| Motor and functional status (6MWT) | Motor status will be captured (ambulant patients): 6-Minute-Walk Test (6MWT): walked distance within 6 min. | Yearly through study completion, an average of 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical SMA characteristics: mechanical ventilation | Change in mechanical ventilation prevalence: percent of participants who required ventilatory support (invasive or non-invasive) | Through study completion, an average of 5 years |
| Clinical SMA characteristics: external nutrition |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study will collect data from SMA patients in Spain, independently of their treatment regimen, age, or disease status, from April 2020 onwards.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| CUIDAME Project Manager | Contact | 0034 936 009 751 | info@registro-cuidame.org |
| Name | Affiliation | Role |
|---|---|---|
| Andrés Nascimento | Hospital Sant Joan de Deu | Study Chair |
| Mónica Povedano Panadés | Hospital Universitari de Bellvitge | Study Chair |
| Francina Munell Casadesús |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Sant Joan de Déu | Recruiting | Esplugues de Llobregat | Spain |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009134 | Muscular Atrophy, Spinal |
| ID | Term |
|---|---|
| D013118 | Spinal Cord Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D016472 | Motor Neuron Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Change in external nutrition prevalence: percent of participants who required external nutrition support |
| Yearly through study completion, an average of 5 years |
| Clinical SMA characteristics: scoliosis | Change in scoliosis presence or scoliosis surgery prevalence: percent of participants who presented scoliosis and percent of participants with spinal surgery. | Yearly through study completion, an average of 5 years |
| Clinical SMA characteristics: neurodevelopmental developoment | Prevalence of neurodevelopmental disorders: percentage of patients who, after assessment by a neuropaediatrician, present with language, behavior, social or understanding alterations | Yearly through study completion, an average of 5 years |
| Clinical SMA characteristics: treatment sequence | change in treatments: distribution of patients in the different possible treatment sequences | Yearly through study completion, an average of 5 years |
| Hospital Universitari Vall d'Hebrón |
| Study Chair |
| Miguel Angel Fernández García Miguel Angel Fernández García | Hospital Universitario La Paz | Study Chair |
| Inmaculada Pitarch Castellano | Hospital Universitario La Fe | Study Chair |
| Juan Francisco Vázquez Costa | Hospital Universitario La Fe | Study Chair |
| Maria Grazia Cattinari | Fundación Atrofia Muscular Espinal | Study Chair |
| Rocío Calvo | Hospital Universitario Regional de Málaga | Study Chair |
| Eduardo Martínez Salcedo | Hospital Universitario Virgen de la Arrixaca | Study Chair |
| Antonio Moreno Escribano | Hospital Universitario Virgen de la Arrixaca | Study Chair |
| Julita Medina Cantillo | Hospital Sant Joan de Deu | Study Chair |
| D019636 | Neurodegenerative Diseases |
| D009468 | Neuromuscular Diseases |